Issue 39, 2019

Photo-controlled delivery of a potent analogue of doxorubicin

Abstract

Highly cytotoxic agents have found an important niche in targeted anticancer therapy. Here we develop a new light release strategy for the targeting of one of these agents, 2-pyrrolinodoxorubicin, showing dramatic enhancements in toxicity with light and single digit nM potency.

Graphical abstract: Photo-controlled delivery of a potent analogue of doxorubicin

Supplementary files

Article information

Article type
Communication
Submitted
13 Mar 2019
Accepted
12 Apr 2019
First published
25 Apr 2019
This article is Open Access
Creative Commons BY-NC license

Chem. Commun., 2019,55, 5607-5610

Photo-controlled delivery of a potent analogue of doxorubicin

P. S. Dupart, K. Mitra, C. E. Lyons and M. C. T. Hartman, Chem. Commun., 2019, 55, 5607 DOI: 10.1039/C9CC02050K

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements